Having diabetes has serious consequences for health and is associated with increased risk of developing diseases related to ...
The Food and Drug Administration (FDA) has approved Tremfya ® (guselkumab) for the treatment of adults with moderately to severely active Crohn disease (CD).
Researchers confirmed that black-legged ticks (Ixodes scapularis) can trigger alpha-gal syndrome in humans. A 10-year ...
Nearly 33,000 Illinoisans without legal status — including 22,000 in Cook County — could be left without health care if ...
When 30-year-old Ella Rhian set off on a dream vacation across Vietnam and Bali, she never imagined a simple meal would alter ...
New study shows that dysfunction of protective immune cells in GI tract may contribute to onset of inflammation in Crohn's disease.
A research team led by Mount Sinai has uncovered mechanisms of abnormal immune cell function that may lead to Crohn's disease ...
The FDA has approved guselkumab (Tremfya) as the first IL-23 inhibitor offering both subcutaneous and intravenous induction ...
The FDA expanded the approval of guselkumab (Tremfya) to include treatment of moderately to severely active Crohn's disease, drugmaker Johnson & Johnson announced on Thursday. An interleukin (IL)-23 ...
Northwell Health has opened a $5.3 million, In Uniondale, a new $5.3M surgical and digestive diseases center Surgical and Digestive Diseases Center. The space is part of the 27,000-square-foot ...
Chronic kidney disease, also called End Stage Renal Failure, describes the gradual loss of kidney function. The kidneys filter waste and excess fluids from the blood, which is then excreted ...
Diabetic foot screening intervals could be extended beyond 1 year for patients at very low risk for diabetic foot complications.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback